SG11202100894XA - Methods for purifying isavuconazonium sulfate - Google Patents
Methods for purifying isavuconazonium sulfateInfo
- Publication number
- SG11202100894XA SG11202100894XA SG11202100894XA SG11202100894XA SG11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA SG 11202100894X A SG11202100894X A SG 11202100894XA
- Authority
- SG
- Singapore
- Prior art keywords
- purifying
- methods
- isavuconazonium sulfate
- isavuconazonium
- sulfate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2018097881 | 2018-08-01 | ||
CN2019090347 | 2019-06-06 | ||
PCT/EP2019/070385 WO2020025553A1 (en) | 2018-08-01 | 2019-07-29 | Methods for purifying isavuconazonium sulfate |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202100894XA true SG11202100894XA (en) | 2021-02-25 |
Family
ID=67660058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202100894XA SG11202100894XA (en) | 2018-08-01 | 2019-07-29 | Methods for purifying isavuconazonium sulfate |
Country Status (13)
Country | Link |
---|---|
US (1) | US20210323959A1 (en) |
EP (1) | EP3830084A1 (en) |
JP (1) | JP7433288B2 (en) |
KR (1) | KR20210040034A (en) |
CN (1) | CN112469717A (en) |
AU (1) | AU2019313525A1 (en) |
BR (1) | BR112021000486A2 (en) |
CA (1) | CA3103888A1 (en) |
IL (1) | IL279667A (en) |
MX (1) | MX2021001116A (en) |
SG (1) | SG11202100894XA (en) |
TW (1) | TW202019920A (en) |
WO (1) | WO2020025553A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023148544A1 (en) * | 2022-02-04 | 2023-08-10 | Glenmark Life Sciences Limited | Crystalline form of isavuconazonium sulfate and a process for its preparation |
WO2023238014A1 (en) * | 2022-06-09 | 2023-12-14 | Optimus Drugs Private Limited | Crystalline form p of isavuconazonium sulfate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1280795E (en) | 1999-11-02 | 2005-06-30 | Basilea Pharmaceutica Ag | N-SUBSTITUTED CARBAMOYL-AZALYL DERIVATIVES |
MX2015007156A (en) | 2012-12-07 | 2015-10-14 | Hoffmann La Roche | Pyridine-2-amides useful as cb2 agonists. |
WO2016016766A2 (en) | 2014-07-26 | 2016-02-04 | Wockhardt Limited | A process for the preparation of isavuconazonium or its salt thereof |
CN106467534B (en) * | 2015-08-17 | 2019-10-11 | 江苏奥赛康药业有限公司 | A kind of sulfuric acid Chinese mugwort Saperconazole compound and its pharmaceutical composition |
CN106565699B (en) | 2015-10-10 | 2019-07-26 | 江苏正大丰海制药有限公司 | A kind of Chinese mugwort Saperconazole vitriol and preparation method thereof |
CN106883226A (en) | 2017-03-30 | 2017-06-23 | 成都绿林科技有限公司 | The preparation method of Ai Shakang azoles sulfuric esters |
CN106916152B (en) | 2017-04-27 | 2019-09-17 | 扬子江药业集团有限公司 | The method of redox reaction preparation Chinese mugwort Saperconazole monosulfate |
-
2019
- 2019-07-29 SG SG11202100894XA patent/SG11202100894XA/en unknown
- 2019-07-29 KR KR1020217001005A patent/KR20210040034A/en unknown
- 2019-07-29 CN CN201980047270.9A patent/CN112469717A/en active Pending
- 2019-07-29 US US17/260,682 patent/US20210323959A1/en active Pending
- 2019-07-29 EP EP19755292.0A patent/EP3830084A1/en active Pending
- 2019-07-29 MX MX2021001116A patent/MX2021001116A/en unknown
- 2019-07-29 JP JP2021505251A patent/JP7433288B2/en active Active
- 2019-07-29 WO PCT/EP2019/070385 patent/WO2020025553A1/en unknown
- 2019-07-29 AU AU2019313525A patent/AU2019313525A1/en not_active Abandoned
- 2019-07-29 BR BR112021000486-6A patent/BR112021000486A2/en unknown
- 2019-07-29 CA CA3103888A patent/CA3103888A1/en active Pending
- 2019-07-31 TW TW108127148A patent/TW202019920A/en unknown
-
2020
- 2020-12-22 IL IL279667A patent/IL279667A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021533116A (en) | 2021-12-02 |
BR112021000486A2 (en) | 2021-04-06 |
JP7433288B2 (en) | 2024-02-19 |
CA3103888A1 (en) | 2020-02-06 |
TW202019920A (en) | 2020-06-01 |
EP3830084A1 (en) | 2021-06-09 |
WO2020025553A1 (en) | 2020-02-06 |
AU2019313525A1 (en) | 2021-01-07 |
US20210323959A1 (en) | 2021-10-21 |
IL279667A (en) | 2021-03-01 |
CN112469717A (en) | 2021-03-09 |
KR20210040034A (en) | 2021-04-12 |
MX2021001116A (en) | 2021-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL271990A (en) | Methods for the purification of l-glufosinate | |
IL281804A (en) | Protein purification methods | |
IL265016B (en) | Methods for purifying antibodies | |
IL280140A (en) | Antigen purification method | |
IL272807A (en) | Method for purifying proteins | |
GB201803724D0 (en) | Methods | |
IL279667A (en) | Methods for purifying isavuconazonium sulfate | |
GB201907882D0 (en) | Methods | |
GB201802486D0 (en) | Methods | |
GB201913716D0 (en) | Methods | |
SG11202007342QA (en) | Methods | |
GB201805466D0 (en) | Methods | |
IL289959A (en) | Methods for purifying antibodies | |
IL277056A (en) | Methods for purifying antibodies | |
GB201600158D0 (en) | Purification method | |
GB2584562B (en) | Purification method | |
GB201906705D0 (en) | Methods | |
GB201903909D0 (en) | Methods | |
GB201901817D0 (en) | Methods | |
HK1257713A1 (en) | Method for protein purification | |
GB201814451D0 (en) | Methods | |
IL276816A (en) | Antibody purification | |
IL287609A (en) | Purification method | |
ZA201905435B (en) | Method for purifying water | |
GB201911910D0 (en) | Methods |